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The use of filamentous fungi as cellular factories, where natural product pathways can
be refactored and expressed in a host strain, continues to aid the field of natural
product discovery. Much work has been done to develop host strains which are
genetically tractable, and for which there are multiple selectable markers and controllable
expression systems. To fully exploit these strains, it is beneficial to understand their
natural metabolic capabilities, as such knowledge can rule out host metabolites from
analysis of transgenic lines and highlight any potential interplay between endogenous and
exogenous pathways. Additionally, once identified, the deletion of secondary metabolite
pathways from host strains can simplify the detection and purification of heterologous
compounds. To this end, secondary metabolite production in Aspergillus oryzae strain
NSAR1 has been investigated via the deletion of the newly discovered negative regulator
of secondary metabolism, mcrA (multicluster regulator A). In all ascomycetes previously
studiedmcrA deletion led to an increase in secondarymetabolite production. Surprisingly,
the only detectable phenotypic change in NSAR1 was a doubling in the yields of kojic
acid, with no novel secondary metabolites produced. This supports the previous claim
that secondary metabolite production has been repressed in A. oryzae and demonstrates
that such repression is not McrA-mediated. Strain NSAR1 was then modified by
employing CRISPR-Cas9 technology to disrupt the production of kojic acid, generating
the novel strain NSAR1K, which combines the various beneficial traits of NSAR1 with a
uniquely clean secondary metabolite background.
Keywords: heterologous host, Aspergillus, natural products, mcrA, secondary metabolism, kojic acid, NSAR1,
NSAR1K
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GRAPHICAL ABSTRACT | Deletion of mcrA led to an increase in kojic acid yields in A. oryzae. Disruption of kojic acid production using CRISPR-Cas9 generated a
novel NSAR1-based strain with a uniquely clean background for the heterologous production of natural products.
INTRODUCTION
Natural products are hugely valuable small molecules, often of
microbial origin, which are used in many industries including
food and cosmetics, and particularly in medicine due to their
varied and potent bioactivities. A pressing need for new lead
compounds, especially antibiotics (Theuretzbacher et al., 2019),
is driving ongoing natural product discovery, especially in
relatively under-exploited groups of microorganisms such as
filamentous fungi. An essential approach in natural product
research is the heterologous expression of secondary metabolite
(SM) pathways. This technique can be employed as a tool
to investigate SM biosynthesis, as a way of discovering novel
compounds, and as a means of production. The filamentous
ascomycete Aspergillus oryzae has been used extensively as a
heterologous host for the production of secondary metabolites
(Watanabe et al., 1998; Heneghan et al., 2010; Chiba et al., 2013;
Williams et al., 2016). Various factors make this fungus a suitable
platform for such work: it has GRAS (“Generally Recognized As
Safe”) status due to its long history of use in food and drink
production, is generally atoxic (Barbesgaard et al., 1992), and
importantly, produces few natural products. Thus, A. oryzae
provides a relatively clean background for the production of
heterologous compounds.
Strain engineering to improve A. oryzae as a heterologous
host has included the development of the multiply auxotrophic
strain NSAR1, which can be transformed with up to four separate
integrative plasmids using different selectable complementation
Abbreviations: SM, Secondary Metabolite; GRAS, Generally Recognized As
Safe; mcrA, multicluster regulator A; BGC, Biosynthetic Gene Cluster; PCR,
Polymerase Chain Reaction; LCMS, Liquid Chromatography Mass Spectrometry;
ELSD, Evaporative Light Scattering Detector; HPLC, High Pressure Liquid
Chromatography; TLC, Thin-Layer Chromatography; CRISPR, Clustered,
Regularly Interspaced Short Palindromic Repeats; Cas, CRISPR-associated
proteins; FAD, Flavin adenine dinucleotide; UV, Ultraviolet; ESI-MS, Electrospray
ionization - Mass Spectrometry; NMR, Nuclear magnetic resonance; PamyB,
promoter for A. oryzae α-amylase; Padh, promoter for A. oryzae alcohol
dehydrogenase; PgpdA, promoter for Aspergillus nidulans glyceraldehyde-3-
phosphate dehydrogenase; Peno, promoter for A. oryzae enolase; argB, Aspergillus
nidulans ornithine carbamoyltransferase gene; AMA1, autonomously maintained
in Aspergillus; RNA, Ribonucleic acid; sgRNA, single chimeric guide RNA;
HH, 5′-end hammerhead ribozyme sequence; HDV, 3′-end hepatitis delta virus
ribozyme sequence; rpm, revolutions per minute.
markers (Jin et al., 2004). This greatly improves the capacity
of A. oryzae to express complex natural products, which
often require the expression of multiple pathway genes. This
capacity has been further expanded by construction of a
set of corresponding plasmids, each containing four different
expression cassettes that provide strong levels of expression in
A. oryzae. Complementation alone therefore allows for the co-
expression of up to 16 different genes in the host organism, while
deployment of similar plasmids based on dominant selectable
markers (the bar gene for resistance to glufosinate ammonium
and ble gene for resistance to phleomycin) could provide a
theoretical total of 24 expressible transgenes (Pahirulzaman et al.,
2012; Lazarus et al., 2014).
A. oryzae has been successfully used as a platform for
the expression of fungal natural product pathways using the
system described above (Wasil et al., 2013; Lazarus et al.,
2014; Bailey et al., 2016; Williams et al., 2016), as well as in
similar independently developed vector systems (Fujii et al., 2011;
Tagami et al., 2013). Such work has allowed complex biosynthetic
pathways to be studied in detail, contributing significantly to
the understanding of fungal SM biosynthesis and uncovering
novel chemistry. Engineered A. oryzae strains can also be used
to generate novel and potentially valuable structural diversity,
through pathway engineering and biotransformations. Alberti
et al. (2017) recently demonstrated the value of such an approach,
establishing A. oryzae as a platform for the production of semi-
synthetic derivatives of the valuable antibiotic pleuromutilin,
one of which demonstrated enhanced antibiotic activity. This
was achieved through the bio-conversion of chemically modified
intermediates that were fed to a transgenic A. oryzae strain.
To fully exploit and further optimize NSAR1 as a “cellular
factory,” it is important to characterize the natural metabolic
capabilities of this strain. This would allow the exclusion of A.
oryzae compounds when analyzing transformants and provide
a better understanding of any potential interplay between
endogenous A. oryzae metabolic pathways and the introduced
natural product pathways. The main metabolite for which A.
oryzae is known is kojic acid 1 (Figure 1), which is a sought-
after product, believed to improve health and beauty, and used
as a chelating agent in various industries including food and
cosmetics (Bentley, 2006). Various strains of A. oryzae have been
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FIGURE 1 | Structure of kojic acid 1.
shown to produce additional secondary metabolites as detailed
in a recent review by Frisvad et al. (2018), but in some cases these
strains have beenmisidentified, and in generalA. oryzae is known
to be a poor producer of SMs.
The relatively low abundance of metabolites reported for A.
oryzae strains is a characteristic that appears to have evolved
since its divergence from the closely related A. flavus. A.
oryzae is thought to be a “domesticated” relative of A. flavus
(Barbesgaard et al., 1992); a hypothesis which is supported by
genome analysis demonstrating that these species are 99.5%
identical (Rokas et al., 2007). Comparison of gene expression
profiles from SM biosynthetic gene clusters (BGCs) between A.
oryzae and A. flavus shows that although numerous SM gene
clusters are present in the genome of A. oryzae, they have been
downregulated and, in many cases, appear totally silent under the
tested conditions (Gibbons et al., 2012).
Recently, a novel negative regulator of secondary metabolism,
McrA (multicluster regulator A), has been discovered in A.
nidulans, where it has been shown to regulate at least 10 SMBGCs
(Oakley et al., 2017). Deletion of mcrA was shown to stimulate
SM production, even in strains carrying a deletion of the global
SM regulator laeA (Bok and Keller, 2004). McrA appears to
be conserved across many ascomycetes, with deletion of mcrA
homologs in A. terreus and Penicillium canescens also resulting
in increased SM production (Oakley et al., 2017).
The initial aim of this research was to identify and delete
the mcrA homolog in A. oryzae in an attempt to induce
SM production and thus better understand the metabolic
capabilities of A. oryzae strain NSAR1. It was reasoned that
the identification of functional biosynthetic pathways in A.
oryzae could also direct strain improvements by targeting
such pathways for deletion, thus creating an even cleaner
background for future work employing A. oryzae as a
cellular factory.
RESULTS
Identification of an A. oryzae mcrA
Homolog
The A. oryzae mcrA homolog was identified by searching for
any A. oryzae protein sequences on the NCBI non-redundant
protein database using the A. nidulans McrA protein sequence
as the query [accession number AN8694 (Oakley et al., 2017)].
Three homologous putative proteins were identified from three
separate A. oryzae strains; A. oryzae 3.042 (Zhao et al., 2012),
A. oryzae BCC7051 (Thammarongtham et al., 2018), and
A. oryzae RIB40 (Machida et al., 2005) (accession numbers:
EIT82532.1, OOO05597.1 and XP_023092425.1, respectively).
These three predicted proteins were all different lengths (366,
318, and 234 amino acids, respectively). The latter two appear
to be truncated at the N-terminus and have an additional
22 amino acid sequence internally (Supplementary Figure 1).
Interrogating the genome sequences of each strain and re-
annotating each gene manually determined that these apparent
differences were due to incorrect annotation. The full protein
sequence previously annotated in the genome of strain 3.042
(Zhao et al., 2012) is present and conserved with 100%
identity in every strain. This protein sequence shares 62%
identity with the A. nidulans McrA with 98% query coverage
(Supplementary Figure 2). This is equivalent to that found and
reported for other Aspergillus strains (Oakley et al., 2017),
suggesting that this protein is also conserved in A. oryzae.
A GAL4-like Zn2Cys6 binuclear cluster DNA-binding domain
(accession number cd00067) was identified from residues 118–
157, supporting the previous assertion that McrA is likely
to function as a transcription factor, or have a similar DNA
binding function.
Disruption of Ao_mcrA
To disrupt Ao_mcrA, a bipartite strategy (Nielsen et al.,
2006) was used. A. oryzae NSAR1 was transformed with the
relevant bi-partite knock-out fragments, containing homology
to the mcrA flanking regions and the argB cassette for
selection, and after multiple rounds of subculturing on selective
media, nine of the resulting transformants were analyzed
by PCR to evaluate integration of the targeting cassette
and subsequent gene disruption (Supplementary Figure 3).
Transformant Ao1mcrA-7 passed all diagnostic tests, with PCRs
confirming correct integration of both bipartite fragments, and
with the transformant being shown to be genetically pure by the
absence of any wild-typemcrA (Supplementary Figure 3).
Metabolite production in strainAo1mcrA-7 was assessed on a
range of media; namely CMP, MEB, PDP, GN, and static rice, and
compared to the parental strain;A. oryzaeNSAR1, to identify any
changes in the metabolic profile as a result of the gene disruption.
On all media, themetabolic profiles were found to be similar, with
no novel metabolites observed. CMP cultures were then used for
further analysis, including purification and quantification, as this
is the medium routinely employed for heterologous production
of compounds in A. oryzae, and supports high yields of crude
extract. Both NSAR1 and Ao1mcrA-7 were fermented in CMP
media for 1 week in triplicate. Quantitative analysis by LCMS
again demonstrated that there were no dramatic changes in the
metabolic profile ofAo1mcrA-7 (Figure 2), with the only evident
change being an increase in the production of kojic acid from 1.23
to 2.52 g/L (Supplementary Table 1).
Fermentation of 1mcrA-7 was scaled up to purify minor
compounds for NMR analysis and subsequent structural
elucidation (Supplementary Figures 4–42). In addition to kojic
acid 1, a kojic acid dimer 2 was also shown to be present
in the extracts. Five diketopiperazines, 3–7, were also isolated
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FIGURE 2 | LCMS traces (ELSD) comparing the crude extracts of A. oryzae strain NSAR1 (bottom trace) and the mcrA deletion strain Ao1mcrA-7 (top trace). The
only observable difference between the strains is an increase in kojic acid production (eluting at 3min) in strain Ao1mcrA-7. The yields were quantified at 1.23 and
2.52 g/L for NSAR1 and Ao1mcrA-7, respectively.
and characterized as the known cyclo-[(D)Pro-(L)Tyr] (3), cyclo-
[(D)Pro-(L)Val] (4), cyclo-[(D)Pro-(L)Ile] (5), cyclo-[(D)Pro-
(L)Leu] (6), and cyclo-[(D)Pro-(L)Phe] (7) (Figure 3). Some of
these compounds have previously been reported as being isolated
from Aspergillus species (Dong et al., 2014; Shaaban et al., 2014;
Uchoa et al., 2017). However, a comparison to extractions from
CMP medium containing no A. oryzae demonstrated that in
this case, these compounds were likely derived from the growth
medium and not A. oryzae (Supplementary Figure 43).
Generation of the kojA Mutant Strain
NSAR1K
To disrupt kojic acid production in strain NSAR1 kojA was
mutated using CRISPR-Cas9 technology. KojA encodes an FAD-
dependent oxidoreductase shown previously to be necessary for
kojic acid production (Terabayashi et al., 2010). A plasmid named
pAYargCas9-kojA2 was constructed, containing Cas9 under the
control of the inducible PamyB promoter and a guide RNA cassette
consisting of the Cas9-binding scaffold sequence and target-
specific guide RNA, placed between the hammerhead (HH) and
hepatitis delta virus (HDV) ribozymes. This design was based on
that of Nødvig et al. (2015) and the use of ribozymes removes the
requirement for an RNA polymerase III promoter. The targeting
guide RNA (sequence GTCGCTCGAACAAAGAAACTCGG;
complementary to nucleotides 90–109 of kojA) was designed
using the online tool WU-CRISPR (Wong et al., 2015), and
chosen based on its high predicted potency and 5′ location.
An Interpro analysis (Mitchell et al., 2019) of KojA identified
an FAD dependent oxidoreductase domain (IPR006076) located
at residues 9–319, placing the target sequence toward the
N-terminus of this domain. The approach used here is known
to generate double-strand breaks (DSBs) at the target locus,
with repair via the NHEJ pathway likely to introduce small
indel (insertion-deletion) mutations (Nødvig et al., 2015). It was
reasoned that any resulting indel mutations at this position,
and particularly any out-of-frame mutations, would likely lead
to a loss of function. pAYargCas9-kojA2 was also designed to
contain the AMA1 autonomously replicating sequence, to allow
for the subsequent loss of the plasmid and recycling of the
selectable marker.
Plasmid pAYargCas9-kojA2 was used to transform A.
oryzae strain NSAR1, generating 42 transformants, which were
transferred onto secondary plates lacking arginine. After two
rounds of subculturing under such selection, transformants
were transferred to KA-Fe medium. This medium contains iron
trichloride (FeCl3), which reacts with kojic acid to produce a
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FIGURE 3 | Compounds extracted from fermentation of 1mcrA-7 in CMP medium.
FIGURE 4 | Sequencing of kojA in the deletion strain NSAR1K identified an 8 bp deletion.
distinct red color, thus acting as an initial screen of kojic acid
production. One transformant, Ao-ko18, failed to trigger such
a color change and was taken forward for further analysis. A
∼1 kb region covering the targeted kojA site was amplified from
both the original NSAR1 strain and Ao-ko18 and sequenced
using primer pair kojA-F/kojA-R. An alignment of the sequences
identified an 8 bp deletion in the mutant strain precisely at the
target site (Figure 4). This out-of-frame deletion is sufficient for
a loss of function for kojA.
To fully confirm a loss of kojic acid production a chemical
extraction was performed for Ao-ko18 fermentation cultures and
the metabolic profile of the resulting crude extract was analyzed
by both TLC and HPLC analysis (Supplementary Figures 44,
45). This confirmed Ao-ko18 as an essentially “empty”
strain, producing no major compounds under our laboratory
production conditions.
Ao-ko18 was then subculturedmultiple times on non-selective
medium (MEA), to allow for the loss of the autonomously
replicating plasmid pAYargCas9-kojA2. This loss was confirmed
by restoration of arginine auxotrophy, and the strain renamed A.
oryzae NSAR1K.
NSAR1K, and the original NSAR1 strain were both
transformed with the pretenellin A 8 producing plasmid pTYGS-
arg-TenC+TenS (Yang et al., 2019), to demonstrate the potential
of using NSAR1K as a platform for the heterologous production
of secondary metabolites. Two resulting strains, 1K-Ten120 and
N-Ten402, were fermented in production medium to induce
the expression of the tenellin genes TenS and TenC. Both
strains were confirmed as producing pretenellin A 8 in similar
yields. In the case of 1K-Ten120, the absence of kojic acid
meant that the crude extract was almost pure pretenellin A 8
(Figure 5). The presence of kojic acid in large quantities can
hinder the purification and downstream use of heterologously
produced metabolites, making NSAR1K a valuable platform for
the heterologous production of secondary metabolites.
DISCUSSION
A 366 amino acid protein – named Ao_mcrA – was identified as
being encoded in the genomes of Aspergillus oryzae strains 3.042,
BCC7051, and RIB40. This protein shares 62% protein identity
with the characterized McrA of Aspergillus nidulans (Oakley
et al., 2017), demonstrating a similar level of homology to that
found and reported for McrA proteins from other Aspergillus
species (Oakley et al., 2017). The conserved GAL4-like Zn2Cys6
binuclear cluster DNA-binding domain could also be detected
within the predicted protein sequence of Ao_mcrA.
Unlike in filamentous fungi previously investigated,
disruption of Ao_mcrA was shown to have little impact on
secondary metabolite (SM) production in A. oryzae strain
NSAR1, with the only observable change being an increase
in the already major metabolite, kojic acid, from 1.23 to 2.52
g/L. As kojic acid is a valuable and commercially produced
compound, a similar deletion of McrA could be conducted in
any producing strains as a potentially straightforward way of
increasing yields. The lack of impact the Ao_mcrA deletion
had on the NSAR1 metabolome provides further evidence
that SM production has been downregulated in A. oryzae
when compared to ancestral Aspergillus species, and that
this downregulation has occurred through means other than
McrA-mediated repression. Previous studies have shown that
both A. oryzae and the closely related A. flavus are actually
enriched in genes for secondary metabolism when compared to
other Aspergillus species (Payne et al., 2006), suggesting that A.
oryzae does have the genetic potential for SM production, but
where A. flavus is a prolific producer of secondary metabolites,
gene clusters in A. oryzae are downregulated (Gibbons et al.,
2012). One interesting avenue for further research would be
to determine whether McrA impacts the transcriptome of A.
oryzae and thus assess whether the expression of gene clusters
has been decoupled from McrA regulation, or whether a factor
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FIGURE 5 | LCMS traces (ELSD) comparing CMP-agar crude extracts of A. oryzae strains heterologously producing pretenellin A 8 (eluting at 14.94min). Strain
N-Ten402 was generated by transforming NSAR1 and is therefore producing kojic acid 1 in addition to pretenellin A 8. Strain 1K-Ten120 was generated using
NSAR1K and is producing almost exclusively pretenellin A 8.
other than transcription is impacting the SM profile of A.
oryzae. It would also be intriguing to determine whether McrA-
mediated repression of secondary metabolism functions as a key
regulatory factor in A. flavus, and thus whether changes in the
role of McrA have occurred during the recent domestication
of A. oryzae.
Although kojic acid 1 is a commercially valuable metabolite,
its production can be problematic in the context of using A.
oryzae as a heterologous host, making chemical extractions and
purification of metabolites more time-consuming and costly.
Therefore, CRISPR-Cas9 technology was harnessed to halt kojic
acid 1 production in an NSAR1 derived strain, through targeted
mutation of kojA, an FAD-dependent oxidoreductase shown
previously to be necessary for kojic acid production (Terabayashi
et al., 2010). The plasmid construction strategy was intentionally
designed so that the addition of the target-specific sgRNA
cassette was the final step. This means that the intermediate
plasmid, pAYargCas9, which contains both the Cas9 and AMA1
cassettes but not the sgRNA cassette, could easily be adapted
to target other loci in strain NSAR1. Targeting kojA led to
the generation of a strain containing an 8 bp deletion at the
target site, with a resulting loss of function and subsequent
inability to produce kojic acid. The kojA mutant strain, named
NSAR1K, was then used as a host for the production of
pretenellin A 8, demonstrating the potential value of this strain
as a platform for the production of commercially important
heterologous compounds.
Slightly surprisingly, the CRISPR-Cas9 approach used here
was found to be relatively inefficient, with only one out of 42
A. oryzae transformants demonstrating a loss of function for
KojA. The low rate of disruption was not especially problematic
in this instance, as rapid screening of kojic acid production is
possible, but may be a hindrance in cases where disruption does
not lead to a clear mutant phenotype. It is possible that the
efficiency of targeting could be improved by the addition of a
template for homology directed repair. Another consideration
worth noting is the possibility of off-target mutations, which are
known to occur with CRISPR-Cas9 editing (Zhang et al., 2015,
Zischewski et al., 2017). Although multiple A. oryzae genome
sequences are available, there is not currently a publicly available
genome sequence for A. oryzaeNSAR1. Sequencing the genomes
of both NSAR1 and the novel strain NSAR1Kwould allow for an
assessment of off-target mutations in strain NSAR1K and would
provide genome data to support any further applications of these
useful strains.
Finally, the isolation of apparent minor metabolites from
crude extracts, which were later identified as diketopiperazines
originating in the culturing medium, serves as a useful warning
to the natural product community to consider all possible sources
of small molecules and to document their presence for exclusion
from future analyses.
Together these findings advanced our understanding of A.
oryzae NSAR1 and led to the development of a new strain
for heterologous production, namely strain NSAR1K. As a
filamentous factory, A. oryzae NSAR1K offers a uniquely
clean background.
MATERIALS AND METHODS
Strains and Culture Conditions
Escherichia coli strain TOP10 (Invitrogen) was used as a host for
plasmids and was maintained according to standard procedures
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TABLE 1 | Primers used in this work. Compound primers, with tails (underlined)
were designed to allow for yeast recombination.









































(Sambrook and Russell, 2001). Saccharomyces cerevisiae strain
YPH499 (Stratagene) was used for plasmid assembly by
homologous recombination and was maintained on YPAD
medium (1% (w/v) yeast extract, 2% (w/v) peptone, 2% (w/v)
glucose, 0.004% (w/v) adenine sulfate, 1.5% (w/v) agar) at
28◦C. A. oryzae NSAR1 was obtained as a gift from the
Kitamoto group and was maintained on MEA medium (Sigma)
at 28◦C (Jin et al., 2004).
Transformation of A. oryzae
Transformation of A. oryzae was performed according to the
protocol outlined by Williams et al. (2016).
A. oryzae Nucleic Acid Extraction
A. oryzae strains were cultured in 10ml GN medium [2% (w/v)
D(+)-glucose monohydrate, 1 % (w/v) Nutrient broth No. 2
(Oxoid, UK)] at 28◦C with shaking at 200 rpm, then pelleted,
lyophilised and ground under liquid nitrogen. Genomic DNA
was prepared using the GenElute Plant Genomic DNAMiniprep
kit (Sigma).
Plasmid Construction for Ao_mcrA
Deletion
Ao_mcrA was deleted from A. oryzae strain NSAR1 using the
bipartite method (Nielsen et al., 2006). This method relies on
the splitting of the selection marker (with a ∼500 bp overlap),
which leads to the requirement for homologous recombination
between the two selection marker halves for selection to occur.
This requirement for homologous recombination leads to higher
gene disruption levels.
A plasmid was constructed using homologous recombination
in S. cerevisiae to provide a template for the bi-partite
fragment amplification (Figure 6). Flanking regions either side
of Ao_mcrA were amplified using the proof-reading polymerase
KAPA HiFi HotStart (Roche), with the primer pairs AO-
mcrAKO-P1F/AO-mcrAKO-P2R and AO-mcrAKO-P3F/AO-
mcrAKOP4R. The argB cassette which provides selection in
A. oryzae NSAR1 was amplified using primer pair PargB-
P5F/TargB-P8R using the plasmid pTYarg as the template
(Lazarus et al., 2014). All three fragments were recombined
into the E. coli/yeast shuttle plasmid pE-YA (Pahirulzaman
et al., 2012), which had been linearised with NotI. The resulting
recombinant plasmid, pE-YA-mcrAKO, was used as a template
for PCR amplification of the bi-partite fragments using primers
AO-mcrAKO-P1F with argB-P6R, and argB-P7F with AO-
mcrAKOP4R. Primers used are shown in Table 1.
Plasmid Construction for kojA Mutation in
NSAR1
A kojA mutant strain of NSAR1 was created using CRISPR-
Cas9 technology, through the construction and application of
plasmid pAYargCas9-kojA2.
Plasmid pAYargCas9-kojA2 was built from the A. oryzae
expression plasmid pTYGS-arg (Lazarus et al., 2014) in multiple
steps (Figure 7). Firstly, cas9 was recombined into pTYGS-
arg by yeast recombination. Cas9 was amplified from plasmid
pKWGF2::hCas9 (Nekrasov et al., 2013) in two overlapping
fragments, to allow the removal of an internal AscI site, using the
primer pairs PamyB-Cas9-F/Cas9-Asc-R and Cas9-Asc-F/Cas9-
TamyB-R. These fragments were combined with pTYGS-arg
digested with NotI, placing cas9 within the amyB cassette and
creating plasmid pTYargCas9. pTYargCas9 was then adapted to
contain the AMA1 autonomously replicating sequence to allow
for extrachromosomal replication rather than integration, and
the subsequent loss of the plasmid to recycle the selectable
marker. This was achieved by digesting pTYargCas9 with
NheI and inserting AMA1 into this break in two overlapping
fragments which were amplified from pFC330 (Nødvig et al.,
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FIGURE 6 | Construction of bi-partite fragments used for the deletion of Ao_mcrA and recombination into the A. oryzae genome.
2015) using the primer pairs AMA1-1F/AMA1-2R and AMA1-
2F/AMA1-1R. Again, this was done via yeast recombination,
yielding the plasmid pAYargCas9. Finally, the single chimeric
guide RNA (sgRNA) was constructed by recombining two PCR
products into pAYargCas9 to place them between the gpdA
promoter and the enolase terminator. This utilized the design
of Nødvig and co-workers (Nødvig et al., 2015) where the
sgRNA is embedded within a larger transcript from which it
is released by the action of two ribozyme sequences; the 5
′
-
end hammerhead (HH) and 3
′
-end hepatitis delta virus (HDV),
which flank the sgRNA. This allows for the use of standard RNA
polymerase II promoters, removing the requirement for an RNA
polymerase III promoter. Portions of the sgRNA cassette were
amplified from plasmid pFC334 (Nødvig et al., 2015) using the
primer pairs Pgpd-kojA2-HH-F/Guide-kojA2-R and HH-kojA2-
Guide-F/Teno-HDV-R. These primers introduced the necessary
kojA-specific sequences including the protospacer, the sgRNA
backbone and the variable HH sequence. The two resulting
PCR products were combined with pAYargCas9 that had been
digested withAscI as well as a short PCR product (amplified using
primer pair ExAdhSeq.F/ExSeqAdh.R) to repair an AscI break
site in another cassette and yeast recombination was conducted
(Figure 7). This produced the final plasmid; pAYargCas9-kojA2,
which was used to transform A. oryzae NSAR1. Primers used in
construction of this plasmid are shown in Table 1.
Screening for Kojic Acid Production From
Putative 1kojA Strains
Putative1kojA transformants were screened by culturing on KA-
Fe solid medium (5% (w/v) glucose, 0.25% (w/v) yeast extract,
0.1% (w/v) K2HPO4, 0.05% (w/v) MgSO4.7H2O, 1mM FeCl3,
2% (w/v) agar, pH 5) (Terabayashi et al., 2010). Kojic acid reacts
with the ferrous chloride in the medium and causes a clear color
change to red. An absence of color change therefore indicates a
loss of kojic acid production.
Genetic Analysis of Transformants
gDNA from nine putative 1mcrA A. oryzae strains was analyzed
using 4 sets of primers (Table 1). The first pair tested for
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FIGURE 7 | Diagram demonstrating the strategy used to construct the pAYargCas9-kojA2 plasmid. Cas9, AMA1, and the guide RNA were each introduced via
consecutive yeast recombinations, as described in the text.
integration of the “left hand” flanking region (primer pair AO-
mcrA-test-F/pArgB-Bg-R). These primers should only amplify a
product if integration has occurred correctly. The second pair
(TargB-Nd-F/AO-mcrA-test-R) tested for correct integration of
the “right-hand” flanking region. The third pair (AO-mcrA-
F/AO-mcrA-R) tested for the presence of the wild-type Ao_mcrA
gene. If the transformants are genetically pure, then no product
should be amplified. As final confirmation, primers AO-mcrA-
test-F/AO-mcrA-test-R were used to amplify over the whole
disrupted region. Primers used are shown in Table 1. Analytical
PCR was performed using Biomix Red (Bioline).
gDNA from A. oryzae NSAR1 and the putative 1kojA
transformant was analyzed using the primer pair kojA-F/kojA-
R (Table 1) which amplified a ∼1 kb product. This was
subsequently sequenced to identify the 8 bp deletion in the1kojA
transformant. Amplification of fragments for sequencing was
performed using the high-fidelity KAPA HiFi HotStart (Roche).
Analytical HPLC
Sample solutions (20 µl) were analyzed using a Waters LCMS
system comprising of a Phenomenex KINETEX column (2.6µ,
C18, 100 Å, 4.6 × 100mm) equipped with a Phenomenex
Security Guard precolumn (Luna C5 300 Å) eluted at 1 ml/min.
Detection was byWaters 2998 Diode Array detector between 200
and 600 nm;Waters 2424 ELSD andWaters SQD-2mass detector
operating simultaneously in ES+ and ES− modes between 100
and 800 m/z. Solvent A was HPLC grade water containing
0.05% formic acid, and solvent B was HPLC grade acetonitrile
containing 0.05% formic acid. Gradient program was as follows:
5–95% of B over 15min. 0min, 5% B; 1min, 5% B; 2min, 40% B;
15min, 95% B; 17min, 95% B; 18min, 5% B; 20min, 5% B; flow
rate 1 ml/min.
NMR Analysis
Instruments used; Varian 400-MR (400 MHz), Varian
VNMRS500 (500 MHz), Bruker 500 Cryo (500 MHz), or
Varian VNMRS600 Cryo (600 MHz). Chemical shifts (δ) quoted
in parts per million (ppm) and coupling constants (J) in Hertz
(Hz), rounded to 0.5Hz intervals. Two-dimensional NMR
techniques (HSQC, COZY, HMBC) were used routinely for the
assignment of structures.
Metabolic Analysis of Strain Ao1mcrA-7
Fermentation and Purification
Initial screens of strain Ao1mcrA-7 were conducted in CMP
(3.5% (w/v) Czapek Dox broth, 2% (w/v) maltose, 1% (w/v)
peptone), MEB (1.7% (w/v) malt extract, 0.3% (w/v) mycological
peptone), PDB (2.4% (w/v) potato dextrose broth), GN [2%
(w/v) D(+)-glucosemonohydrate, 1% (w/v) Nutrient broth No. 2
(Oxoid, UK)] and rice (50 g of rice, autoclaved in 50ml of distilled
H2O). Cultures were grown for 1 week at 28◦C with shaking at
180 rpm, with the exception of the rice culture which is a static
culture (28◦C). Cultures were extracted with an equal volume of
ethyl acetate and analyzed by LCMS.
For purification of compounds, strain Ao1mcrA-7 was
cultured for 3 days in CMP medium at 28◦C. This seed culture
was then used to inoculate 2 l of CMP. The flasks were shaken at
180 rpm at 28◦C for 1 week. The broth was filtered by Buchner
filtration and extracted with ethyl acetate (1.5 l× 3). The organic
layers were concentrated under reduced pressure to give 7.4 g of
crude extract. The major product 1 (3.6 g) was crystallized out
from ethyl acetate. Themother liquor was then chromatographed
by reversed-phase silica gel column chromatography eluted with
acetonitrile/water (v/v, from 1:3 to 1:0) to yield 3 fractions (F1–
F3). From fraction F2 (320mg), 2 (7.4mg), a mixture of 3 and 4
(13.5mg), 5 (3.8mg), 6 (2.5mg), and 7 (3.5mg) were afforded by
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preparative LCMS (Luna 5µ C18 100 Å, 250× 10mm, 8 ml/min)
using a 20min 5–60% acetonitrile in water (+ 0.1% formic acid).
Isolated Metabolites
Kojic acid (1), white crystals, UV λmax 216, 268 nm, ESI-MS m/z
143 [M+H]+. 1HNMR (500MHz, CD3OD, δH): 4.41 (2H, s, H-
6), 6.50 (1H, s, H-4), 7.96 (1H, s, H-1); δC (125 MHz, CD3OD)
61.4 (C-6), 110.9 (C-4), 141.2 (C-1), 147.6 (C-2), 170.6 (C-5),
177.1 (C-3). These data were in agreement with the reported
literature (Kingsbury et al., 1976).
Kojic acid dimer (2), white amorphous powder, UV λmax
216, 273 nm, ESI-MS m/z 283 [M + H]+. 1H NMR (500 MHz,
CD3OD, δH): 4.35 (1H, d, J = 12.0Hz, H-12a), 4.41 (1H, d, J =
12.0Hz, H-12b), 5.94 (1H, s, H-6), 6.49 (1H, s, H-10), 6.73 (1H, s,
H-4), 7.94 (1H, s, H-1); δC (125 MHz, CD3OD) 61.1 (C-12), 65.9
(C-6), 110.1 (C-10), 111.7 (C-4), 141.2 (C-1), 144.5 (C-8), 147.6
(C-2), 147.9 (C-7), 168.1 (C-5), 170.1 (C-11), 176.6 (C-9), 176.7
(C-3). These data were in agreement with the reported literature
(Nakagawa et al., 1993).
A mixture (1:1) of compounds 3 and 4was obtained as a white
amorphous powder. Cyclo-[(D)Pro-(L)Tyr] (3), ESI-MS m/z 261
[M+H]+. 1HNMR (500 MHz, CD3OD, δH): 1.95 (2H, m, H-3a
and 4a), 2.04 (1H, m, H-4b), 2.33 (1H, m, H-3b), 3.07 (2H, m,
H-8), 3.57 (2H, m, H-5), 4.22 (1H, m, H-2), 4.38 (1H, m, H-7),
6.72 (2H, d, J = 8.5Hz, H-11 and H-13), 7.04 (2H, d, J = 8.5Hz,
H-10 and H-14); δC (125 MHz, CD3OD) 23.3 (C-4), 29.5 (C-3),
37.7 (C-8), 46.2 (C-5), 57.9 (C-7), 60.1 (C-2), 116.2 (C-11 and C-
13), 127.6 (C-9), 132.1 (C-10), 157.7 (C-12), 166.9 (C-6), 172.5
(C-1). These data were in agreement with the reported literature
(Kumar et al., 2012).
Cyclo-[(D)Pro-(L)Val] (4), ESI-MS m/z 197 [M + H]+. 1H
NMR (500MHz, CD3OD, δH): 0.95 (3H, d, J = 7.5Hz, H-9), 1.11
(3H, d, J = 7.5Hz, H-10), 1.24 (1H, m, H-3a), 1.81 (2H, m, H-4),
2.11 (1H, m, H-3b), 2.51 (1H, m, H-8), 3.36 (1H, m, H-5a), 3.52
(1H, m, H-5b), 4.05 (1H, m, H-7), 4.07 (1H, m, H-2); δC (125
MHz, CD3OD) 16.7 (C-9), 18.4 (C-10), 22.7 (C-4), 29.4 (C-3),
29.9 (C-8), 45.9 (C-5), 60.1 (C-2), 61.5 (C-7), 167.6 (C-6), 170.7
(C-1). These data were in agreement with the reported literature
(Kwon et al., 2001).
Cyclo-[(D)Pro-(L)Ile] (5), white amorphous powder, [α]+ 72◦
(c 0.01, MeOH), ESI-MSm/z 211 [M+H]+. 1HNMR (500MHz,
CD3OD, δH): 0.96 (3H, d, J = 7.5Hz, H-10), 1.08 (3H, d, J =
7.5Hz, H-11), 1.34 (1H, m, H-9a), 1.47 (1H, m, H-9b), 1.95 (2H,
m, H-3a and H-4a), 2.04 (1H, m, H-4b), 2.34 (1H, m, H-3b), 3.07
(1H, m, H-8), 3.50-3.58 (2H, m, H-5), 4.09 (1H, m, H-7), 4.21
(1H, m, H-2); δC (125 MHz, CD3OD) 12.6 (C-10), 15.5 (C-11),
23.2 (C-4), 25.4 (C-9), 29.6 (C-3), 37.1 (C-8), 60.0 (C-2), 61.3 (C-
7), 167.5 (C-6), 172.4 (C-1). These data were in agreement with
the reported literature (Bull et al., 1998).
Cyclo-[(D)Pro-(L)Leu] (6), white amorphous powder, [α] –
142◦ (c 0.01, MeOH), UV λmax 210 nm, ESI-MS m/z 211 [M +
H]+. 1H NMR (500 MHz, CD3OD, δH): 0.97 (6H, m, H-10 and
H-11), 1.53 (1H, m, H-8a), 1.91 (2H, m, H-4a and H-9), 1.95 (1H,
m, H-9b), 2.03 (1H, m, H-4b), 2.31 (1H, m, H-3b), 3.53 (1H,
m, H-5), 4.14 (1H, m, H-7), 4.27 (1H, m, H-2); δC (125 MHz,
CD3OD) 20.8 (C-10), 21.9 (C-11), 22.2 (C-4), 24.4 (C-9), 27.7
(C-3), 37.9 (C-8), 45.0 (C-5), 53.2 (C-7), 58.9 (C-2), 167.5 (C-
6), 171.3 (C-1). These data were in agreement with the reported
literature (Kumar et al., 2012).
Cyclo-[(D)Pro-(L)Phe] (7), white amorphous powder, [α] +
51◦ (c 0.01, MeOH), UV λmax 210 nm, ESI-MS m/z 245 [M +
H]+. 1HNMR (500 MHz, CD3OD, δH): 1.24 (1H, m, H-3a), 1.81
(2H, m, H-4), 2.11 (1H, m, H-3a), 3.19 (2H, m, H-8), 3.40 (1H,
m, H-5a), 3.54 (1H, m, H-5b), 4.10 (1H, m, H-2), 4.45 (1H, m,
H-7), 7.23 – 7.31 (5H, m, H-10, 11, 12, 13, 14); δC (125 MHz,
CD3OD) 22.8 (C-4), 29.4 (C-3), 38.2 (C-8), 45.9 (C-5), 57.7 (C-
7), 60.1 (C-2), 128.1 (C-12), 129.4 (C-11 and C-13), 131.0 (C-10
and C-14), 137.3 (C-9), 166.8 (C-6), 170.9 (C-1). These data were
in agreement with the reported literature (Kumar et al., 2013).
Fermentation and Chemical Analysis of
Tenellin Producing Strains
Strains 1K-Ten120 and N-Ten402 were cultured on solid CMP
medium (3.5% (w/v) Czapek Dox broth, 2% (w/v) maltose, 1%
(w/v) peptone, 2% (w/v) agar) for 5 days at 28◦C. Subsequently,
1 cm2 plugs of agar from the rim and the center of growing
colonies were extracted in 2ml of a solution of ethyl acetate,
dichloromethane and methanol (3:2:1) with 1% acetic acid. After
1 h in an ultrasonic bath, the liquid was removed and dried.
The crude extract was then dissolved in 200 µl acetonitrile and
analyzed by HPLC-MS/UV/ELSD.
Kojic Acid Quantitative Analysis
Kojic Acid Calibration Curve
Acetonitrile solutions containing specific kojic acid
concentrations were prepared (0.25–1.5 mg/ml) and injected into
our HPLC system in triplicate. The calibration curve was created
by regression analysis plotting the kojic acid concentrations
(mg/ml) with the area of the peak obtained from the ELSD
chromatogram. The relationship was linear within the 0.25–1.50
mg/ml concentration range and the lower limit of detection was
0.20 mg/ml (Supplementary Figure 46). The obtained linear
regression equation, y = 18784x – 5527.7 (with the coefficient
of correlation r2 = 0.98), was then applied to quantify kojic acid
in the crude extracts. All analyses were performed in triplicate,
and the statistical analysis of the data was achieved by using
Microsoft Office Excel 2016.
Sample Preparation
Strains A. oryzae NSAR1 and Ao1mcrA-7 were cultured for 2
days in CMP media at 28◦C. From this seeding culture, 200 µl
was used to inoculate conical flasks containing 50ml of CMP. The
flasks were then shaken at 180 rpm at 28◦C for 1 week. The broths
were separated from the mycelium, and a 10ml portion of each
culture was extracted with ethyl acetate (10ml) by shaking for
3min. A 5ml portion of the organic layer was then concentrated
under nitrogen gas to give a crude extract. The crude extract
was then dissolved in acetonitrile at the concentration of 1
mg/ml for HPLC injection. Each extraction was performed
in triplicate.
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